Price (delayed)
$1.32
Market cap
$88.17M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.19
Enterprise value
$158.14M
Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent
There are no recent dividends present for GBIO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.